These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30949886)

  • 21. Significant decrease in plasma N-acetyl-seryl-aspartyl-lysyl-proline level in patients with end stage renal disease after kidney transplantation.
    Suzuki Y; Katagiri F; Sato F; Fujioka K; Sato Y; Fujioka T; Sato Y; Mimata H; Itoh H
    Biol Pharm Bull; 2014; 37(6):1075-9. PubMed ID: 24882420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.
    Srivastava SP; Goodwin JE; Kanasaki K; Koya D
    Br J Pharmacol; 2020 Aug; 177(16):3691-3711. PubMed ID: 32352559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients.
    Jiang X; Zhang Q; Wang HB; Cui XF; Liu R
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28236320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetyl-seryl-aspartyl-lysyl-proline inhibits diabetes-associated kidney fibrosis and endothelial-mesenchymal transition.
    Nagai T; Kanasaki M; Srivastava SP; Nakamura Y; Ishigaki Y; Kitada M; Shi S; Kanasaki K; Koya D
    Biomed Res Int; 2014; 2014():696475. PubMed ID: 24783220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
    Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
    PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated Urinary VEGF-A, Transferrin, and Angiotensinogen Levels in Normoalbuminuric Children and Adolescents with Type 1 Diabetes: Can They Be Early Markers of Diabetic Kidney Disease?
    Dağdeviren Çakır A; Saygılı SK; Canpolat N; Konukoğlu D; Turan H; Çalışkan S; Sever L; Ercan O; Evliyaoğlu O
    Horm Res Paediatr; 2021; 94(11-12):426-432. PubMed ID: 34915504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline.
    Zhang Y; Zhang ZG; Chopp M; Meng Y; Zhang L; Mahmood A; Xiong Y
    J Neurosurg; 2017 Mar; 126(3):782-795. PubMed ID: 28245754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podocyturia parallels proximal tubule dysfunction in type 2 diabetes mellitus patients independently of albuminuria and renal function decline: A cross-sectional study.
    Petrica L; Vlad M; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Popescu R; Gluhovschi C; Matusz P; Velciov S; Bob F; Ursoniu S; Vlad D
    J Diabetes Complications; 2017 Sep; 31(9):1444-1450. PubMed ID: 28161386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1.
    Mise K; Imamura M; Yamaguchi S; Teshigawara S; Tone A; Uchida HA; Eguchi J; Nakatsuka A; Ogawa D; Yoshida M; Yamada M; Shikata K; Wada J
    Diabetes Care; 2018 Aug; 41(8):1765-1775. PubMed ID: 29930140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients.
    Silveiro SP; Friedman R; de Azevedo MJ; Canani LH; Gross JL
    Diabetes Care; 1996 Feb; 19(2):171-4. PubMed ID: 8718441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study.
    Iida T; Hosojima M; Kabasawa H; Yamamoto-Kabasawa K; Goto S; Tanaka T; Kitamura N; Nakada M; Itoh S; Ogasawara S; Kaseda R; Suzuki Y; Narita I; Saito A
    J Diabetes Complications; 2022 Nov; 36(11):108312. PubMed ID: 36228564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
    Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
    Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients.
    Sheen YJ; Lin JL; Li TC; Bau CT; Sheu WH
    J Diabetes Complications; 2014; 28(6):779-84. PubMed ID: 25219331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes.
    Suh JS; Kim SH; Cho KS; Jung IA; Cho WK; Jeon YJ; Jung MH; Suh BK
    Pediatr Nephrol; 2016 Apr; 31(4):623-31. PubMed ID: 26525196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis.
    Srivastava SP; Shi S; Kanasaki M; Nagai T; Kitada M; He J; Nakamura Y; Ishigaki Y; Kanasaki K; Koya D
    Sci Rep; 2016 Jul; 6():29884. PubMed ID: 27425816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
    Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Knowler WC; Rovin BH; Wu H; Klein JB; Mifflin TE; Feldman HI; Vasan RS; Kimmel PL; Kusek JW; Mauer M;
    Nephrol Dial Transplant; 2015 Apr; 30(4):599-606. PubMed ID: 25648911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.